Literature DB >> 11446671

Hepatic necrosis with cholestasis induced by long-term voglibose administration.

S Kawakami1, T Arima, K Harada, H Miyazono, M Oketani, H Miyazaki, T Arima.   

Abstract

A 76-year-old woman admitted to our hospital for jaundice had been treated for diabetes mellitus with insulin for 9 years and voglibose had been added for the 39 months preceding admission. Elevated serum bilirubin and transaminase concentration began to normalize with initiation of corticosteroid treatment 1 week after discontinuation of voglibose. In the in vitro testing of the patient's peripheral blood, lymphocytes showed stimulation by voglibose. In dramatic contrast to an initial liver biopsy specimen that demonstrated cholestasis with submassive and zonal necrosis, the follow-up specimen was normal 1 year later. We believe that patients treated with voglibose should be monitored long-term with monthly determinations of transaminases and bilirubin in serum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446671     DOI: 10.2169/internalmedicine.40.484

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

2.  Effective therapy using voglibose for nonalcoholic steatohepatitis in a patient with insufficient dietary and exercise therapy: exploring other treatment possibilities.

Authors:  Kazuki Nagai; Katsuhiko Matsumaru; Yutaka Takahashi; Noriko Nakamura
Journal:  Case Rep Gastroenterol       Date:  2011-06-10

3.  Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report.

Authors:  Heba Ismail
Journal:  Cases J       Date:  2009-06-17

Review 4.  Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis.

Authors:  Ramesh Kumar
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.